Comparison Chart Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.82 USD | +2.31% |
|
-1.08% | -3.87% |
| 02-09 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) added to S&P 400 Health Care | CI |
| 02-09 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) added to S&P 400 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +2.31% | -1.08% | -3.87% | +233.96% | -27.64% | 8.94B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ARWR Stock
- Charts Arrowhead Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition